Leap Therapeutics, Inc. Gains 33.44%
Leap Therapeutics, Inc. (LPTX:NASDAQ) soared at $0.72, representing a gain of 33.4%. On Fri, Jan 20, 2023, LPTX:NASDAQ hit a New 2-Week High of $0.72. The stock got featured on our News Catalysts scanner on Wed, Jan 18, 2023 at 03:03 AM in the 'BIOTECH' category. From Fri, Jan 06, 2023, the stock recorded 55.56% Up Days and 60.00% Green Days
The stock spiked on Thu, Sep 08, 2022 at $1.86 with a volume of 1M+.
About Leap Therapeutics, Inc. (LPTX:NASDAQ)
Leap Therapeutics Inc is a biopharmaceutical company . The Company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology.
Top 10 Gainers:
- Lytus Technologies Holdings PTV. Ltd. (LYT:NASDAQ), 83.07%
- Helbiz Inc. (HLBZ:NASDAQ), 65.48%
- Genius Group Limited (GNS:NYSEMKT), 55.02%
- Astronics Corporation (ATRO:NASDAQ), 41.78%
- CN Energy Group Inc. (CNEY:NASDAQ), 39.58%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 35.18%
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 33.44%
- Akanda Corp. (AKAN:NASDAQ), 29.58%
- Sema4 Holdings Corp. (SMFR:NASDAQ), 26.78%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 26.58%